Our Resources | Association for Accessible Medicines

Nov 19, 2019 | Erica Klinger

USMCA: Nothing to See Here (Infographic)

Nov 19, 2019 | Jonathan Kimball

Myths vs. Facts of Biologic Market Exclusivity in Mexico — #FixUSMCA

Nov 18, 2019 | Erica Klinger

Dispensary of Hope: The Industry’s Nonprofit Supply-Chain Partner

Nov 14, 2019 | Erica Klinger

How Our Associate Members Make the World Healthier

GRx+Biosims Day 3 Healthcare Innovation and The Political Economy

Nov 11, 2019 | Erica Klinger

GRx+Biosims Year 2: The Recap

FDA - Nomination of Dr. Stephen Hahn to FDA

Nov 1, 2019 | Rachel Schwartz

AAM Statement on Nomination of Dr. Stephen Hahn to FDA

Generic Rx World Manufacturing

Oct 29, 2019 | Rachel Schwartz

AAM Testimony on the Generic Global Supply Chain—Five Takeaways

AAM Statement on 2019 FDA Drug Shortages

Oct 29, 2019 | Rachel Schwartz

AAM Statement on 2019 FDA Drug Shortages Task Force Report

Oct 29, 2019 | Jennifer Soup

GRx+Biosims: Back + Better Than Ever

Oct 23, 2019 | Rachel Schwartz

AAM Launches #DoesntAddUp Ad Campaign to Bring Down Prescription Drug Costs for Patients in the U.S.

Oct 22, 2019 | Erica Klinger

Associate Member Operation Smile: A Catalyst for Increasing Access to Safe Surgery

Oct 16, 2019 | Rachel Schwartz

AAM Reaction to FDA Statement on Patient Access to Generic Drugs